Cancer News and Research

Latest Cancer News and Research

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.

19 May 2011

Generic drugs to rule the market in the near future: Experts

According to the latest estimates for global drug sales, generic drug makers are going to be in for bumper profits. The growth in generics is expected to depress overall ‘pharma’ sales growth, as lower-priced copies replace top-dollar brand names. In fact, global sales growth could be reduced by half over the next five years, say experts.

19 May 2011

Allergy towards electricity after chemotherapy

Janice Tunnicliffe, 55 has become allergic to electromagnetic fields and electricity after a course of chemotherapy for bowel cancer. Fortunately, despite the size of the tumor, her cancer had not spread, but it was decided that she should have chemotherapy after the surgery as a precautionary measure.

19 May 2011

Scientists identify key protein behind drug-resistant leukemia

Acute lymphoblastic leukemia, or ALL, is the most common form of childhood cancer. While most children treated for this disease survive, in a subgroup of patients the disease does not respond to treatment.

19 May 2011

APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Gemcitabine HCI for Injection, USP, in the 2 g dosage strength. APP will launch this presentation of Gemcitabine immediately.

19 May 2011

Two genes linked to worst cases of esophageal cancer

University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.

19 May 2011

MDC researchers comprehensively quantify gene expression for the first time

How do genes control us? This fundamental question of life still remains elusive despite decades of research. Genes are blueprints for proteins, but it is the proteins that actually carry out vital functions in the body for maintaining life. Diseases such as cancer are not only characterized by altered genes, but also by disturbed protein production.

19 May 2011

New breast cancer biomarker may help identify women's response to tamoxifen

Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.

19 May 2011

Study suggests link between obesity, psoriasis and heart disease risk in children

Children who are overweight or obese have a significantly higher prevalence of psoriasis, and teens with psoriasis, regardless of their body weight, have higher cholesterol levels, according to a Kaiser Permanente study published online in the Journal of Pediatrics.

19 May 2011

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Pfizer Inc. today announced data from the pivotal Phase 3 AXIS 1032 trial, showing that in patients with previously treated advanced renal cell carcinoma, axitinib significantly extended progression-free survival at the 47th Annual American Society of Clinical Oncology meeting in Chicago from June 3-7, 2011.

19 May 2011

Yoga offers unique benefits beyond fighting fatigue for women with breast cancer

For women with breast cancer undergoing radiation therapy, yoga offers unique benefits beyond fighting fatigue, according to new research from The University of Texas MD Anderson Cancer Center.

19 May 2011

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.

19 May 2011

Heavy alcohol consumption linked to increased risk of gastric cancer

The results from a very well-done meta-analysis support other data generated on the risk of alcohol consumption and gastric cancer - that is - that the risk may be real for heavy alcohol consumption but not for moderate intake.

19 May 2011

A new gene expression analysis technique on a single molecule sequencer

A new gene expression technique adapted for single molecule sequencing has enabled researchers at the RIKEN Omics Science Center (OSC) to accurately and quantitatively measure gene expression levels using only 100 nanograms of total RNA. The technique, which pairs RIKEN's Cap Analysis of Gene Expression (CAGE) protocol with the Helicos(R) Genetic Analysis System developed by Helicos BioSciences Corporation, opens the door to the detailed analysis of gene expression networks and rare cell populations. In recent years, next-generation DNA sequencers have produced an increasingly detailed picture of how genes are expressed at the molecular level. The transcriptional output of these genes - the RNA copies produced from DNA - has revealed a richness of complexity in transcript structure and function, providing insights into the molecular-level properties of cancers and other diseases.

19 May 2011

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Abbott announced today that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR (polymerase chain reaction) test for measuring the viral load of hepatitis C (HCV), the leading cause of liver cancer in the United States.

19 May 2011

Estradiol may exacerbate tumor growth in breast cancer

A recently discovered enzyme drives the production of a potent form of estrogen in human breast cancer tissue, researchers from the University of Illinois at Chicago College of Medicine have found.

19 May 2011

Common gene fault triggers a ripple of molecular signals leading to more aggressive cervical cancer

Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.

19 May 2011

Mayo Clinic develops new screening procedure for Lynch syndrome detection

Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.

19 May 2011

'Gatekeeper' protein plays a key role in skin-cancer prevention

New research from North Carolina State University shows that a "gatekeeper" protein plays an important role in skin-cancer prevention in humans and lab mice.

19 May 2011

Vitamin D plays a key role in protection against childhood asthma

Vitamin D, which is primarily absorbed from the sun, plays a role in protection against childhood asthma. Now, a new study led by Valencian researchers has shown that children who live in colder, wetter cities are at greater risk of suffering from this respiratory problem, since there are fewer hours of sunlight in such places.

19 May 2011

Cancer News and Research

Latest Cancer News and Research

Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting

Generic drugs to rule the market in the near future: Experts

Allergy towards electricity after chemotherapy

Scientists identify key protein behind drug-resistant leukemia

APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage

Two genes linked to worst cases of esophageal cancer

MDC researchers comprehensively quantify gene expression for the first time

New breast cancer biomarker may help identify women's response to tamoxifen

Study suggests link between obesity, psoriasis and heart disease risk in children

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Yoga offers unique benefits beyond fighting fatigue for women with breast cancer

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Heavy alcohol consumption linked to increased risk of gastric cancer

A new gene expression analysis technique on a single molecule sequencer

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Estradiol may exacerbate tumor growth in breast cancer

Common gene fault triggers a ripple of molecular signals leading to more aggressive cervical cancer

Mayo Clinic develops new screening procedure for Lynch syndrome detection

'Gatekeeper' protein plays a key role in skin-cancer prevention

Vitamin D plays a key role in protection against childhood asthma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in